Novartis AG Receipts From Royalties Fees Commissions And Other Revenue
Novartis AG (NVSEF) reported Receipts From Royalties Fees Commissions And Other Revenue of $300.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Income Statement › Other Income
ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue · last filed 2026-02-04
- Novartis AG receipts from royalties fees commissions and other revenue for the quarter ending 2025-06-30 was $300.00M.
| Period end | Receipts From Royalties Fees Commissions And Other Revenue 3 month | Receipts From Royalties Fees Commissions And Other Revenue 6 month | Receipts From Royalties Fees Commissions And Other Revenue 12 month |
|---|---|---|---|
| 2025-12-31 | $300.00M 20-F · filed 2026-02-04 | ||
| 2025-06-30 | $300.00M 6-K · filed 2025-07-17 | $300.00M 6-K · filed 2025-07-17 |